# Trade Desk, Inc.: financial statements, quarterly

TTD · Nasdaq · CIK 1671933 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ttd.md) · [Financials](/companies/ttd/financials.md) · [Filings](/companies/ttd/filings.md) · [Insiders](/companies/ttd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ttd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [493](/filings/0001671933-24-000122.md) | [606 d](/filings/0001671933-26-000014.md) | [491](/filings/0001671933-25-000062.md) | [585](/filings/0001671933-25-000125.md) | [628](/filings/0001671933-25-000144.md) | [741 d](/filings/0001671933-26-000014.md) | [616](/filings/0001671933-26-000054.md) | [694](/filings/0001671933-26-000086.md) | [739](/filings/0001671933-25-000144.md) | [847 d](/filings/0001671933-26-000014.md) | [689](/filings/0001671933-26-000054.md) | [715](/filings/0001671933-26-000086.md) |
| Cost of revenue | $m | [93.4](/filings/0001671933-24-000122.md) | [101 d](/filings/0001671933-26-000014.md) | [104](/filings/0001671933-25-000062.md) | [110](/filings/0001671933-25-000125.md) | [123](/filings/0001671933-25-000144.md) | [135 d](/filings/0001671933-26-000014.md) | [143](/filings/0001671933-26-000054.md) | [151](/filings/0001671933-26-000086.md) | [162](/filings/0001671933-25-000144.md) | [163 d](/filings/0001671933-26-000014.md) | [182](/filings/0001671933-26-000054.md) | [184](/filings/0001671933-26-000086.md) |
| Research and development | $m | [118](/filings/0001671933-24-000122.md) | [102 d](/filings/0001671933-26-000014.md) | [108](/filings/0001671933-25-000062.md) | [110](/filings/0001671933-25-000125.md) | [118](/filings/0001671933-25-000144.md) | [128 d](/filings/0001671933-26-000014.md) | [132](/filings/0001671933-26-000054.md) | [134](/filings/0001671933-26-000086.md) | [128](/filings/0001671933-25-000144.md) | [131 d](/filings/0001671933-26-000014.md) | [143](/filings/0001671933-26-000054.md) | [141](/filings/0001671933-26-000086.md) |
| Operating income | $m | [37.7](/filings/0001671933-24-000122.md) | [144 d](/filings/0001671933-26-000014.md) | [28.7](/filings/0001671933-25-000062.md) | [94.7](/filings/0001671933-25-000125.md) | [108](/filings/0001671933-25-000144.md) | [195 d](/filings/0001671933-26-000014.md) | [54.5](/filings/0001671933-26-000054.md) | [117](/filings/0001671933-26-000086.md) | [161](/filings/0001671933-25-000144.md) | [257 d](/filings/0001671933-26-000014.md) | [66.6](/filings/0001671933-26-000054.md) | [102](/filings/0001671933-26-000086.md) |
| Interest expense | $m | not reported | not reported | [0.4](/filings/0001671933-25-000062.md) | [0.4](/filings/0001671933-25-000125.md) | [0.4](/filings/0001671933-25-000144.md) | [0.4 d](/filings/0001671933-26-000014.md) | [0.4](/filings/0001671933-26-000054.md) | [0.4](/filings/0001671933-26-000086.md) | [0.4](/filings/0001671933-25-000144.md) | [0.7 d](/filings/0001671933-26-000014.md) | [0.4](/filings/0001671933-26-000054.md) | [0.7](/filings/0001671933-26-000086.md) |
| Income tax | $m | [17.6](/filings/0001671933-24-000122.md) | [63.4 d](/filings/0001671933-26-000014.md) | [14.4](/filings/0001671933-25-000062.md) | [27.5](/filings/0001671933-25-000125.md) | [33.0](/filings/0001671933-25-000144.md) | [39.4 d](/filings/0001671933-26-000014.md) | [25.1](/filings/0001671933-26-000054.md) | [43.1](/filings/0001671933-26-000086.md) | [64.0](/filings/0001671933-25-000144.md) | [83.3 d](/filings/0001671933-26-000014.md) | [39.0](/filings/0001671933-26-000054.md) | [48.7](/filings/0001671933-26-000086.md) |
| Net income | $m | [39.4](/filings/0001671933-24-000122.md) | [97.3 d](/filings/0001671933-26-000014.md) | [31.7](/filings/0001671933-25-000144.md) | [85.0](/filings/0001671933-25-000144.md) | [94.2](/filings/0001671933-25-000144.md) | [182 d](/filings/0001671933-26-000014.md) | [50.7](/filings/0001671933-26-000086.md) | [90.1](/filings/0001671933-26-000086.md) | [116](/filings/0001671933-25-000144.md) | [187 d](/filings/0001671933-26-000014.md) | [40.0](/filings/0001671933-26-000086.md) | [64.4](/filings/0001671933-26-000086.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001671933-24-000122.md) | not reported | [0.06](/filings/0001671933-25-000062.md) | [0.17](/filings/0001671933-25-000125.md) | [0.19](/filings/0001671933-25-000144.md) | not reported | [0.10](/filings/0001671933-26-000054.md) | [0.18](/filings/0001671933-26-000086.md) | [0.23](/filings/0001671933-25-000144.md) | not reported | [0.08](/filings/0001671933-26-000054.md) | [0.14](/filings/0001671933-26-000086.md) |
| Basic EPS | $ per share | [0.08](/filings/0001671933-24-000122.md) | not reported | [0.06](/filings/0001671933-25-000062.md) | [0.17](/filings/0001671933-25-000125.md) | [0.19](/filings/0001671933-25-000144.md) | not reported | [0.10](/filings/0001671933-26-000054.md) | [0.18](/filings/0001671933-26-000086.md) | [0.24](/filings/0001671933-25-000144.md) | not reported | [0.08](/filings/0001671933-26-000054.md) | [0.14](/filings/0001671933-26-000086.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1,072](/filings/0001671933-23-000050.md) | [895](/filings/0001671933-25-000029.md) | [918](/filings/0001671933-24-000059.md) | [1,009](/filings/0001671933-24-000090.md) | [1,221](/filings/0001671933-24-000122.md) | [1,369](/filings/0001671933-26-000014.md) | [1,119](/filings/0001671933-25-000062.md) | [896](/filings/0001671933-25-000125.md) | [653](/filings/0001671933-25-000144.md) | [658](/filings/0001671933-26-000086.md) | [878](/filings/0001671933-26-000054.md) | [1,123](/filings/0001671933-26-000086.md) |
| Current assets | $m | [4,014](/filings/0001671933-23-000050.md) | [4,314](/filings/0001671933-25-000029.md) | [4,096](/filings/0001671933-24-000059.md) | [4,523](/filings/0001671933-24-000090.md) | [4,838](/filings/0001671933-24-000122.md) | [5,336](/filings/0001671933-26-000014.md) | [4,856](/filings/0001671933-25-000062.md) | [5,054](/filings/0001671933-25-000125.md) | [5,120](/filings/0001671933-25-000144.md) | [5,261](/filings/0001671933-26-000086.md) | [4,862](/filings/0001671933-26-000054.md) | [4,816](/filings/0001671933-26-000086.md) |
| Total assets | $m | [4,520](/filings/0001671933-23-000050.md) | [4,889](/filings/0001671933-25-000029.md) | [4,664](/filings/0001671933-24-000059.md) | [5,160](/filings/0001671933-24-000090.md) | [5,505](/filings/0001671933-24-000122.md) | [6,112](/filings/0001671933-26-000014.md) | [5,705](/filings/0001671933-25-000062.md) | [5,958](/filings/0001671933-25-000125.md) | [5,940](/filings/0001671933-25-000144.md) | [6,153](/filings/0001671933-26-000086.md) | [5,734](/filings/0001671933-26-000054.md) | [5,764](/filings/0001671933-26-000086.md) |
| Current liabilities | $m | [2,147](/filings/0001671933-23-000050.md) | [2,511](/filings/0001671933-25-000029.md) | [2,283](/filings/0001671933-24-000059.md) | [2,518](/filings/0001671933-24-000090.md) | [2,615](/filings/0001671933-24-000122.md) | [2,873](/filings/0001671933-26-000014.md) | [2,682](/filings/0001671933-25-000062.md) | [2,949](/filings/0001671933-25-000125.md) | [2,995](/filings/0001671933-25-000144.md) | [3,266](/filings/0001671933-26-000086.md) | [2,890](/filings/0001671933-26-000054.md) | [2,794](/filings/0001671933-26-000086.md) |
| Total liabilities | $m | [2,365](/filings/0001671933-23-000050.md) | [2,724](/filings/0001671933-25-000029.md) | [2,497](/filings/0001671933-24-000059.md) | [2,755](/filings/0001671933-24-000090.md) | [2,880](/filings/0001671933-24-000122.md) | [3,163](/filings/0001671933-26-000014.md) | [2,989](/filings/0001671933-25-000062.md) | [3,262](/filings/0001671933-25-000125.md) | [3,340](/filings/0001671933-25-000144.md) | [3,669](/filings/0001671933-26-000086.md) | [3,281](/filings/0001671933-26-000054.md) | [3,190](/filings/0001671933-26-000086.md) |
| Shareholders' equity | $m | [2,156](/filings/0001671933-24-000122.md) | [2,164](/filings/0001671933-26-000014.md) | [2,167](/filings/0001671933-25-000144.md) | [2,405](/filings/0001671933-25-000144.md) | [2,626](/filings/0001671933-25-000144.md) | [2,949](/filings/0001671933-26-000086.md) | [2,717](/filings/0001671933-26-000086.md) | [2,696](/filings/0001671933-26-000086.md) | [2,601](/filings/0001671933-25-000144.md) | [2,484](/filings/0001671933-26-000086.md) | [2,453](/filings/0001671933-26-000086.md) | [2,574](/filings/0001671933-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [192 d](/filings/0001671933-24-000122.md) | [91.1 d](/filings/0001671933-26-000014.md) | [185](/filings/0001671933-25-000062.md) | [81.3 d](/filings/0001671933-25-000125.md) | [273 d](/filings/0001671933-25-000144.md) | [199 d](/filings/0001671933-26-000014.md) | [291](/filings/0001671933-26-000054.md) | [165 d](/filings/0001671933-26-000086.md) | [225 d](/filings/0001671933-25-000144.md) | [312 d](/filings/0001671933-26-000014.md) | [392](/filings/0001671933-26-000054.md) | [154 d](/filings/0001671933-26-000086.md) |
| Capital expenditure | $m | [5.0 d](/filings/0001671933-24-000122.md) | [25.2 d](/filings/0001671933-26-000014.md) | [7.2](/filings/0001671933-25-000062.md) | [22.1 d](/filings/0001671933-25-000125.md) | [48.7 d](/filings/0001671933-25-000144.md) | [20.2 d](/filings/0001671933-26-000014.md) | [59.1](/filings/0001671933-26-000054.md) | [45.2 d](/filings/0001671933-26-000086.md) | [66.3 d](/filings/0001671933-25-000144.md) | [26.3 d](/filings/0001671933-26-000014.md) | [113](/filings/0001671933-26-000054.md) | [13.2 d](/filings/0001671933-26-000086.md) |
| Share repurchases | $m | [90.2 d](/filings/0001671933-24-000122.md) | [220 d](/filings/0001671933-26-000014.md) | [125](/filings/0001671933-25-000062.md) | [0.0 d](/filings/0001671933-25-000125.md) | [52.1 d](/filings/0001671933-25-000144.md) | [57.4 d](/filings/0001671933-26-000014.md) | [386](/filings/0001671933-26-000054.md) | [261 d](/filings/0001671933-26-000086.md) | [310 d](/filings/0001671933-25-000144.md) | [423 d](/filings/0001671933-26-000014.md) | [164](/filings/0001671933-26-000054.md) | [77.8 d](/filings/0001671933-26-000086.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [500](/filings/0001671933-23-000050.md) | [500](/filings/0001671933-24-000059.md) | [499](/filings/0001671933-24-000090.md) | [502](/filings/0001671933-24-000122.md) | [498](/filings/0001671933-25-000062.md) | [500](/filings/0001671933-25-000125.md) | [503](/filings/0001671933-25-000144.md) | [503](/filings/0001671933-26-000054.md) | [496](/filings/0001671933-26-000086.md) | [493](/filings/0001671933-25-000144.md) | [477](/filings/0001671933-26-000054.md) | [470](/filings/0001671933-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.